ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Operating income 2017–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) annual operating income history from SEC filings — each fiscal year as reported.
-$57.1MFY2025 · since FY2017: -$44.5M → -$57.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$57.1M | +64.9% |
| FY2024 | -$162.5M | +28.4% |
| FY2023 | -$227.0M | -13.4% |
| FY2022 | -$200.2M | +4.2% |
| FY2021 | -$209.0M | -36.7% |
| FY2020 | -$152.8M | -94.9% |
| FY2019 | -$78.4M | -57.6% |
| FY2018 | -$49.8M | -11.9% |
| FY2017 | -$44.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice